113 related articles for article (PubMed ID: 21569259)
21. Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson's Disease and Progressive Supranuclear Palsy.
Quattrone A; Morelli M; Bianco MG; Buonocore J; Sarica A; Caligiuri ME; Aracri F; Calomino C; De Maria M; Vaccaro MG; Gramigna V; Augimeri A; Vescio B; Quattrone A
Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884755
[TBL] [Abstract][Full Text] [Related]
22. Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities.
Ruiz-Barrio I; Horta-Barba A; Illán-Gala I; Kulisevsky J; Pagonabarraga J
Front Neurol; 2022; 13():861585. PubMed ID: 35557621
[TBL] [Abstract][Full Text] [Related]
23. FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation.
Deng B; Zheng Z; Zheng J; Yang W; Huang Y; Luo Y; Jin D; Shen L; Jin K; Wang Q
Aging Dis; 2021 Oct; 12(7):1741-1752. PubMed ID: 34631218
[TBL] [Abstract][Full Text] [Related]
24. Social Cognition Deficits Are Pervasive across Both Classical and Overlap Frontotemporal Dementia Syndromes.
Arshad F; Paplikar A; Mekala S; Varghese F; Purushothaman VV; Kumar DJ; Shingavi L; Vengalil S; Ramakrishnan S; Yadav R; Pal PK; Nalini A; Alladi S
Dement Geriatr Cogn Dis Extra; 2020; 10(3):115-126. PubMed ID: 33442389
[TBL] [Abstract][Full Text] [Related]
25. Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
Fujita K; Matsubara T; Miyamoto R; Sumikura H; Takeuchi T; Maruyama Saladini K; Kawarai T; Nodera H; Udaka F; Kume K; Morino H; Kawakami H; Hasegawa M; Kaji R; Murayama S; Izumi Y
BMC Neurol; 2019 Jul; 19(1):168. PubMed ID: 31319800
[TBL] [Abstract][Full Text] [Related]
26. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
[TBL] [Abstract][Full Text] [Related]
27. Combined Pathologies in FTLD-TDP Types A and C.
Gefen T; Ahmadian SS; Mao Q; Kim G; Seckin M; Bonakdarpour B; Ramos EM; Coppola G; Rademakers R; Rogalski E; Rademaker A; Weintraub S; Mesulam MM; Geula C; Bigio EH
J Neuropathol Exp Neurol; 2018 May; 77(5):405-412. PubMed ID: 29584904
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
Gasca-Salas C; Masellis M; Khoo E; Shah BB; Fisman D; Lang AE; Kleiner-Fisman G
PLoS One; 2016; 11(4):e0153852. PubMed ID: 27100392
[TBL] [Abstract][Full Text] [Related]
29. Parkinsonism, movement disorders and genetics in frontotemporal dementia.
Baizabal-Carvallo JF; Jankovic J
Nat Rev Neurol; 2016 Mar; 12(3):175-85. PubMed ID: 26891767
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of saccades in movement disorder patients: a practical guide and review.
Termsarasab P; Thammongkolchai T; Rucker JC; Frucht SJ
J Clin Mov Disord; 2015; 2():14. PubMed ID: 26788350
[TBL] [Abstract][Full Text] [Related]
31. Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases.
Natale G; Pompili E; Biagioni F; Paparelli S; Lenzi P; Fornai F
Eur J Histochem; 2013 Mar; 57(1):e5. PubMed ID: 23549464
[TBL] [Abstract][Full Text] [Related]
32. Circulating progranulin as a biomarker for neurodegenerative diseases.
Ghidoni R; Paterlini A; Benussi L
Am J Neurodegener Dis; 2012; 1(2):180-90. PubMed ID: 23383391
[TBL] [Abstract][Full Text] [Related]
33. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease.
Espay AJ; Spina S; Houghton DJ; Murrell JR; de Courten-Myers GM; Ghetti B; Litvan I
J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):751-3. PubMed ID: 20587488
[TBL] [Abstract][Full Text] [Related]
34. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R
Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581
[TBL] [Abstract][Full Text] [Related]
35. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
36. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
37. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
[TBL] [Abstract][Full Text] [Related]
38. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
